NASDAQ · HTFL
Heartflow, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for HTFL: Nov 12, 2026
Heartflow, Inc. Common Stock is expected to report earnings on 11/12/2026 after market close. The report will be for the fiscal Quarter ending Sep 2026. According to Zacks Investment Research, based on 4 analysts' forecasts, the consensus EPS forecast for the quarter is $-0.18. The reported EPS for the same quarter last year was $-0.35.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $-0.18 | $-0.16 | $-0.20 | 4 |
| Dec 2026 | $-0.18 | $-0.17 | $-0.20 | 4 |
| Mar 2027 | $-0.16 | $-0.15 | $-0.16 | 3 |
| Jun 2027 | $-0.15 | $-0.12 | $-0.17 | 3 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
Zacks · RTTNews · The Motley Fool · Fintel- Zacks · Oct 27, 5:20 PM EDTPulmonx Corporation (LUNG) Reports Q3 Loss, Tops Revenue EstimatesPulmonx (LUNG) delivered earnings and revenue surprises of +26.92% and +3.75%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
- RTTNews · Oct 6, 3:37 AM EDTBiotech Stocks At 52-Week Highs – PCVX +31% On Phase 3 Results, INFU, ILMN +7%, CRL+7%, HTFL +5%(RTTNews) – The following biotech stocks reached a 52-week high on October 5, 2026, driven by key catalysts such as encouraging clinical research data.
- RTTNews · Sep 21, 9:35 AM EDTBiotech Stocks At 52-Week Highs – HSCS +7%, FRNM +5%, VOGX, HTFL, HALO(RTTNews) – The following biotech stocks reached a 52-week high on September 18, 2026, driven by the gain on certain clinical trial results or an announced public offering.
- The Motley Fool · Sep 15, 3:56 PM EDTHeartFlow's CEO Sells 38,900 Shares for $1.8 Million After the Stock Hit a 52-Week HighThe transaction involved 38,900 shares valued at ~$1.8 million based on a weighted average price of $46.78 per share.
- Fintel · Sep 9, 2:46 PM EDTUBS Initiates Coverage of HeartFlow at NeutralFintel reports that on September 9, 2026, UBS initiated coverage of HeartFlow (NASDAQGS:HTFL) with a Neutral recommendation.Prior to this rating action, the stock closed at $47.75 on September 8, 2026. This latest close represents a price change of -5.31% over one week, compared
- The Motley Fool · Sep 6, 2:11 AM EDTHeartFlow CFO Dumps Over 33,000 Shares for $1.7 Million as the Stock Hits a 52-Week HighThe sale of 33,416 shares generated a total value of approximately $1.7 million based on a weighted average execution price of $49.85.
- RTTNews · Aug 28, 2:07 PM EDTHeartflow FFRCT Cuts Unnecessary Invasive Heart Procedures 44% In FUSION Trial(RTTNews) – Heartflow, Inc. (HTFL), an AI technology company focused on diagnosing and managing coronary artery disease (CAD), announced one-year results from the independent, government-funded FUSION trial.
- RTTNews · Aug 25, 4:00 AM EDTBiotech Stocks At 52-Week Highs – VOGX, PHVS, SOLV, IKT, HTFL(RTTNews) – The following biotech stocks reached a 52-week high on August 24, 2026, driven by positive results from clinical trials or an upcoming conference participation.
- The Motley Fool · Aug 20, 12:00 PM EDTHeartFlow's Chief Medical Officer Sells 9,219 Shares Amid a Soaring Stock Price. What Does That Mean for Investors?The executive sold 9,219 shares at $41.23 per share on August 17, 2026, generating ~$380,100.
- RTTNews · Aug 17, 8:22 AM EDTHeartflow Q2 Loss Widens Despite 48% Jump In Revenue, Lifts FY26 Outlook(RTTNews) – Heartflow, Inc. (HTFL), a healthcare technology company using artificial intelligence to diagnose and manage coronary artery disease, reported strong revenue growth, however with wider loss reflecting a surge in operating expenses, compared to the prior year.
- The Motley Fool · Aug 14, 7:44 PM EDTWhy Heartflow Stock Soared TodayHeartflow's AI-powered platform could save countless lives.
- MarketBeat · Aug 13, 9:04 PM EDTHeartflow Q2 Earnings Call HighlightsHeartflow (NASDAQ:HTFL) reported second-quarter revenue of $64.1 million, up 48% from a year earlier, as growth in its Plaque Analysis offering, durable FFR-CT utilization and continued expansion of the coronary CT angiography, or CCTA, market supported results. U.S. revenue ros
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for Heartflow, Inc. from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.